Chris J. Garabedian
Angel · California
Board director at 5 startups that filed Form D raises since late 2024, mostly in California.
- Stages
- Seed to Growth
- Typical check (est.)
- Not disclosed
- Latest fund
- None on file
- Last verified activity
- Mar 2025
Focus
Biotech & PharmaHealthcareRecent portfolio activity
Sources
- SEC Form D: Tellus TherapeuticsFeb 21, 2023
- SEC Form D: VivoSenseOct 30, 2023
- SEC Form D: AsclepiX TherapeuticsApr 26, 2024
- SEC Form D: Marea TherapeuticsJun 24, 2024
- SEC Form D: Zucara TherapeuticsMar 6, 2025
Profile last verified Oct 12, 2026. Is this you? Correct or remove this profile.